150 research primates got diarrhea, flooding lab with priceless vaccine data
Researchers now have clear new targets and insights for developing a Shigella vaccine.
In a surprising turn of events, over 150 non-human primates at a research center experienced a prolonged two-year outbreak of severe diarrhea. While this may seem like an unfortunate occurrence, it provided invaluable data for scientists striving to find a cure for the bacteria responsible, Shigella. In a newly published study in Science Translational Medicine, researchers analyzed the immunological data from these infections and identified potential strategies to train immune cells to combat Shigella.
By pinpointing specific target molecules within the bacteria, researchers were able to understand the immune system's most effective responses to the germ. This breakthrough also allowed scientists to identify the precise notches on these molecules where antibodies attach, demonstrating a newfound understanding of the intricate workings of the immune system's fight against Shigella.
The study's findings reveal unexpected aspects of the anti-Shigella antibody response in naturally infected primates and pave the way for the rational design of potential Shigella vaccine candidates.
Written by urgent.news from Ars Technica's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
This story
This is one outlet's version. Read the fullest account.
